Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,023 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pivotal role for S-nitrosylation of DNA methyltransferase 3B in epigenetic regulation of tumorigenesis.
Okuda K, Nakahara K, Ito A, Iijima Y, Nomura R, Kumar A, Fujikawa K, Adachi K, Shimada Y, Fujio S, Yamamoto R, Takasugi N, Onuma K, Osaki M, Okada F, Ukegawa T, Takeuchi Y, Yasui N, Yamashita A, Marusawa H, Matsushita Y, Katagiri T, Shibata T, Uchida K, Niu SY, Lang NB, Nakamura T, Zhang KYJ, Lipton SA, Uehara T. Okuda K, et al. Among authors: takeuchi y. Nat Commun. 2023 Feb 4;14(1):621. doi: 10.1038/s41467-023-36232-6. Nat Commun. 2023. PMID: 36739439 Free PMC article.
[Comparison of two cases of type 2 autoimmune pancreatitis].
Ikeda S, Mori T, Takeuchi Y, Takagaki K, Uemura T, Shirai N. Ikeda S, et al. Among authors: takeuchi y. Nihon Shokakibyo Gakkai Zasshi. 2021;118(12):1151-1159. doi: 10.11405/nisshoshi.118.1151. Nihon Shokakibyo Gakkai Zasshi. 2021. PMID: 34897145 Japanese.
Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab".
Kikuchi T, Takeuchi Y, Nouso K, Kariyama K, Kuwaki K, Toshimori J, Iwado S, Moriya A, Hagihara H, Takabatake H, Tada T, Yasunaka T, Sakata M, Sue M, Miyake N, Adachi T, Wada N, Onishi H, Shiraha H, Takaki A, Otsuka M. Kikuchi T, et al. Among authors: takeuchi y. Liver Int. 2024 May 8. doi: 10.1111/liv.15964. Online ahead of print. Liver Int. 2024. PMID: 38717049 No abstract available.
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.
Rejnmark L, Gosmanova EO, Khan AA, Makita N, Imanishi Y, Takeuchi Y, Sprague S, Shoback DM, Kohlmeier L, Rubin MR, Palermo A, Schwarz P, Gagnon C, Tsourdi E, Zhao C, Makara MA, Ominsky MS, Lai B, Ukena J, Sibley CT, Shu AD. Rejnmark L, et al. Among authors: takeuchi y. Adv Ther. 2024 Apr 30. doi: 10.1007/s12325-024-02843-8. Online ahead of print. Adv Ther. 2024. PMID: 38691316
4,023 results